Clinical trial
Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction of TNM Staging System in Nasopharyngeal Carcinoma: A Prospective Multi-institutional Observation Study
NCT02211677 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction of TNM Staging System in Nasopharyngeal Carcinoma: A Prospective Multi-institutional Observation Study
- Lead sponsor
- Sun Yat-sen University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- December 31, 2024
- Enrollment
- 720 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
blood cell count, nasopharyngeal neoplasms, neoplasm staging, prognosis